Wound care companies set to make joint approach to NICE (National Institute of Clinical Excellence)
This article was originally published in Clinica
Wound care manufacturers are meeting at the offices of the Association of British Health-Care Industries (ABHI) in the UK on September 6 to discuss a common industry submission to the National Institute of Clinical Excellence (NICE) on appraising debriding agents for difficult to heal surgical wounds.
You may also be interested in...
Lannett will launch a further seven products in fiscal 2021, after launching four products recently in the first quarter of FY21. The company also plans to pay off its Term Loan ‘A’ in full, by the end of November 2020.
Pfizer has now received a formal European Commission approval for its Nyvepria biosimilar pegfilgrastim. The approval puts the firm in direct competition with several other versions of the Neulasta original.
AstraZeneca's research head admits that the half dose approach was a lucky mistake – but one that could boost the vaccine's effectiveness and supplies. The US regulator may not be persuaded, however.